Institutional members access full text with Ovid®

Share this article on:

Oncofertility: An Emerging Discipline in Obstetrics and Gynecology

Lange, Sara MD*; Tait, David MD; Matthews, Michelle MD

Obstetrical & Gynecological Survey: August 2013 - Volume 68 - Issue 8 - p 582–593
doi: 10.1097/OGX.0b013e31829d460d
CME Articles: Oncofertility in Obstetrics and Gynecology

Oncofertility is an exciting new interdisciplinary field that encompasses the obstetrician gynecologist, gynecologic oncologist, reproductive endocrinologist, and primary care physician in a common goal to provide fertility preservation options for cancer patients. Maintaining their fertility is of the upmost importance for many oncology patients diagnosed during their childbearing years. This review addresses the common types of cancers in reproductive-age patients and how the treatment of these cancers may impact reproductive potential. Fertility preservation treatments will also be discussed to assist health care providers in appropriately counseling patients about options after a diagnosis of cancer. The goal of oncofertility is to provide both physicians and patients with the knowledge and resources to make fertility an ongoing opportunity for all patients who desire a future with children.

Target Audience: Obstetricians and gynecologists, medical/surgical oncologists, family physicians

Learning Objectives: After completing this CME activity, physicians should be better able to manage patients with gynecological cancers, evaluate the impact of cancer treatment on fertility, and counsel patients regarding potential fertility-sparing treatment options.

*Resident Physician, †Associate Director, Gynecologic Oncology, and ‡Associate Director, Reproductive Endocrinology/Infertility, Carolinas Medical Center, Charlotte, NC

The authors have disclosed that the US Food and Drug Administration has not approved the use of gonadotropin-releasing hormone agonists for ovarian suppression during chemotherapy as discussed in this article. Please consult the products’ labeling for approved information.

All authors and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations pertaining to this educational activity.

Correspondence requests to: David Tait, MD, 1021 Morehead Medical Dr, Charlotte, NC 28204. E-mail: david.tait@carolinashealthcare.org.

© 2013 by Lippincott Williams & Wilkins.